-
The Economic Value of Self-Administered Subcutaneous Immunoglobulin G (SCIg) in Canada: A Scoping Review
Sep 9, 2025, 16:22 PM -
Scoping the Future: Using NICE Scopes to Inform PICO Prediction for EU Joint Clinical Assessment
Sep 9, 2025, 16:22 PM -
Patient Acceptance of Health Information Technologies: Comparative Insights From Wearables, TelE-Medicine, and mHealth
Sep 9, 2025, 16:22 PM -
Development and Validation of a Novel Patient Microsimulation Cost-Effectiveness Model to Evaluate Automated Insulin Delivery Systems in Type 2 Diabetes
Sep 9, 2025, 16:22 PM -
Impacts of Patient-Centered Collaboration: Application of a Continuous Engagement Plan Across Multiple Phases of the Insights and Patient Experiences With Cardiovascular Disease (IPEC) Initiative
Sep 9, 2025, 16:22 PM -
Accelerating Therapeutic Innovation: Early Results From France’s Accès Direct Scheme
Sep 9, 2025, 16:22 PM -
Mortality in COPD and Cardiovascular Disease Comorbidity: Survival Analysis Using Curated Data From Brazilian Public Healthcare System (SUS)
Sep 9, 2025, 16:22 PM -
Perspectives of Patients and Caregivers on Relapsed/Refractory Acute Myeloid Leukemia Treatments: A Mixed-Methods Interview Study
Sep 9, 2025, 16:22 PM -
Inefficiencies in Developing UK and Irish HTA Submissions and How to Streamline the Process
Sep 9, 2025, 16:22 PM -
Current Treatment Pathway for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in England: Insights From a Qualitative Validation With Clinical Experts
Sep 9, 2025, 16:22 PM -
Epidemiology of Pulmonary Arterial Hypertension In France: A Real-World Study Using the French National Healthcare Database (SNDS)
Sep 9, 2025, 16:22 PM -
Are We Measuring What Matters in Postpartum Depression Trials?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Peripheral Neuropathy Screening in Malaysian Adults With Thalassemia: An Integrated Modeling Approach
Sep 9, 2025, 16:22 PM -
Systems-Level Modeling Approaches for Complex Health Technologies: A Systematic Review
Sep 9, 2025, 16:22 PM -
Challenges in Defining Target Populations: An Analysis of Orphan Drug Health Technology Assessments in Germany 2024
Sep 9, 2025, 16:22 PM -
Economic Impact of Lenalidomide-Refractory Multiple Myeloma in Finland: Insights From Real-World Data
Sep 9, 2025, 16:22 PM -
Delta Price Cost-Effectiveness Analysis of PCV21 vs. PCV20 Use in Adults Aged ≥18 Years in Austria
Sep 9, 2025, 16:22 PM -
Development of the Eating Drivers Diary (EDDY): A Novel Patient-Reported Outcome Measure for Use in Clinical Trials of Medications for Weight Reduction
Sep 9, 2025, 16:22 PM -
Machine Learning for Missing Data Imputation in Healthcare Research: A Systematic Review of Methods and Applications
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Secukinumab for Moderate to Severe Hidradenitis Suppurativa in Portugal
Sep 9, 2025, 16:22 PM
